Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mertens

Showing results (161-170 of 211) with videos related to

Pageof 22
Sort By:
BJU International|March 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancerAleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri, et al.
Nature Medicine|February 27, 2026
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trialJan-Jaap J Mellema, Chantal F Stockem, Cameron Herberts, et al.
BJU International|March 26, 2025
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidatesMario de Angelis, Pietro Scilipoti, Alfonso Santangelo, et al.
BJU International|February 7, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomyFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
Minerva Urology and Nephrology|September 20, 2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Wojciech Krajewski, Jose D Subiela, et al.
Annals of Surgical Oncology|March 21, 2026
Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder CancerAleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, et al.
European Urology|April 28, 2023
Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in MalesAlberto Martini, Ugo Giovanni Falagario, Antonio Russo, et al.
European Urology Oncology|June 24, 2026
Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter AnalysisAleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, et al.
European Urology Focus|May 20, 2025
Long-term Oncological Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG TreatmentPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
Cancers|April 13, 2023
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-AnalysisFrancesco Del Giudice, Vincenzo Asero, Eugenio Bologna, et al.
Pageof 22

Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
BJU International|March 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancerAleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri, et al.
Nature Medicine|February 27, 2026
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trialJan-Jaap J Mellema, Chantal F Stockem, Cameron Herberts, et al.
BJU International|March 26, 2025
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidatesMario de Angelis, Pietro Scilipoti, Alfonso Santangelo, et al.
BJU International|February 7, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomyFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
Minerva Urology and Nephrology|September 20, 2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Wojciech Krajewski, Jose D Subiela, et al.
Annals of Surgical Oncology|March 21, 2026
Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder CancerAleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, et al.
European Urology|April 28, 2023
Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in MalesAlberto Martini, Ugo Giovanni Falagario, Antonio Russo, et al.
European Urology Oncology|June 24, 2026
Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter AnalysisAleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, et al.
European Urology Focus|May 20, 2025
Long-term Oncological Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG TreatmentPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
Cancers|April 13, 2023
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-AnalysisFrancesco Del Giudice, Vincenzo Asero, Eugenio Bologna, et al.
Pageof 22